Skip to main content

Advertisement

SpringerLink
Log in

Effect of duloxetine on pain and opioid consumption after total knee and hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials

  • Review Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background

Although duloxetine has shown a positive effect on pain relief with hip and knee osteoarthritis, there is no pooled analysis of duloxetine for pain relief and opioid consumption in patients after total hip or knee arthroplasty.

Aim

This systematic review and meta-analysis aimed to analyze pain control, opioid consumption, and associated adverse events of perioperative administration of duloxetine after total hip or knee arthroplasty.

Method

After being registered with PROSPERO (CRD42022323202), the databases of MEDLINE, PubMed, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov were searched from inception until March 20, 2023, for randomized controlled trials (RCTs). Primary outcomes were the visual Analog Scale (VAS) pain scores at rest (rVAS) and upon ambulation (aVAS). Secondary outcomes were postoperative opioid consumption quantified as oral morphine milligram equivalents (MMEs) and adverse effects of duloxetine.

Results

Nine RCTs with 806 cases were included. Duloxetine was associated with lower VAS scores at different times after surgery (24 h, two weeks, and ≥ 3 months). Compared to placebo, perioperative daily duloxetine use significantly reduced daily opioid MMEs at 24 h (standard mean deviation [SMD] −0.71, 95% confidence interval [95% CI] −1.19 to −0.24, P = 0.003), three days (SMD −1.10, 95% CI −1.70 to −0.50, P = 0.0003), and one week (SMD −1.18, 95% CI −1.99 to −0.38, P = 0.004) after surgery. The duloxetine group had a significantly lower rate of nausea (odds ratio 0.62, 95% CI [0.41 to 0.94], P = 0.02) and a higher rate of drowsiness and somnolence (odds ratio 1.87, 95% CI [1.13 to 3.07], P = 0.01) compared to the placebo group. No significant differences were observed in the rates of other adverse events.

Conclusion

 Perioperative duloxetine significantly decreased postoperative pain and opioid consumption with good safety profiles. Further high quality designed and well-controlled randomized trials are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Bashinskaya B, Zimmerman RM, Walcott BP, et al. Arthroplasty utilization in the United States is predicted by age-specific population groups. ISRN Orthop. 2012;2012:185938.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ackerman IN, Bohensky MA, Zomer E, et al. The projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030. BMC Musculoskelet Disord. 2019;20(1):90.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Karam JA, Schwenk ES, Parvizi J. An update on multimodal pain management after total joint arthroplasty. J Bone Joint Surg Am. 2021;103(17):1652–62.

    Article  PubMed  Google Scholar 

  4. Beswick AD, Wylde V, Gooberman-Hill R, et al. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open. 2012;2(1):e000435.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Joshi GP, Ogunnaike BO. Consequences of inadequate postoperative pain relief and chronic persistent postoperative pain. Anesthesiol Clin North Am. 2005;23(1):21–36.

    Article  PubMed  Google Scholar 

  6. Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev. 2014;2014(1):Cd007115.

    PubMed  PubMed Central  Google Scholar 

  7. Ammitzbøll N, Arendt-Nielsen L, Bertoli D, et al. A mechanism-based proof of concept study on the effects of duloxetine in patients with painful knee osteoarthritis. Trials. 2021;22(1):958.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Braillon A. Efficacy and safety of duloxetine in osteoarthritis or chronic low back pain? The tip of an iceberg! Osteoarthritis Cartilage. 2020;28(9):1298–9.

    Article  CAS  PubMed  Google Scholar 

  9. Brown JP, Boulay LJ. Clinical experience with duloxetine in the management of chronic musculoskeletal pain. A focus on osteoarthritis of the knee. Ther Adv Musculoskelet Dis. 2013;5(6):291–304.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Branton MW, Hopkins TJ, Nemec EC. Duloxetine for the reduction of opioid use in elective orthopedic surgery: a systematic review and meta-analysis. Int J Clin Pharm. 2021;43(2):394–403.

    Article  CAS  PubMed  Google Scholar 

  11. Yuan M, Tang T, Ding Z, et al. Analgesic effect of perioperative duloxetine in patients after total knee arthroplasty: a prospective, randomized, double-blind, placebo-controlled trial. BMC Musculoskelet Disord. 2022;23(1):242.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. YaDeau JT, Mayman DJ, Jules-Elysee KM, et al. Effect of duloxetine on opioid use and pain after total knee arthroplasty: a triple-blinded randomized controlled trial. J Arthroplasty. 2022;37(6S):S147–54.

    Article  PubMed  Google Scholar 

  13. Koh IJ, Kim MS, Sohn S, et al. Duloxetine reduces pain and improves quality of recovery following total knee arthroplasty in centrally sensitized patients: a prospective, randomized controlled study. J Bone Joint Surg Am. 2019;101(1):64–73.

    Article  PubMed  Google Scholar 

  14. Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.

    Article  PubMed  Google Scholar 

  16. Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of postoperative pain: a clinical practice guideline from the American pain society, the American society of regional anesthesia and pain medicine, and the American society of anesthesiologists’ committee on regional anesthesia, executive committee, and administrative council. J Pain. 2016;17(2):131–57.

    Article  PubMed  Google Scholar 

  17. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1–2):9–19.

    Article  PubMed  Google Scholar 

  18. Centers for Disease Control and Prevention. Analyzing Prescription Data and Morphine Milligram Equivalents (MME). https://www.cdc.gov/opioids/data-resources/index.html. Accessed 28 Mar 2023.

  19. Lossio-Ventura JA, Song W, Sainlaire M, et al. Opioid2MME: standardizing opioid prescriptions to morphine milligram equivalents from electronic health records. Int J Med Inform. 2022;162:104739.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Ding ZC, Li H, Huang C, et al. Significant analgesic benefits of perioperative duloxetine in patients who have depressive symptoms undergoing total hip arthroplasty: A randomized controlled trial. J Arthroplasty. 2023;38(3):519–24.

    Article  PubMed  Google Scholar 

  22. Ho KY, Tay W, Yeo MC, et al. Duloxetine reduces morphine requirements after knee replacement surgery. Br J Anaesth. 2010;105(3):371–6.

    Article  CAS  PubMed  Google Scholar 

  23. Kim MS, Koh IJ, Sung YG, et al. Preemptive duloxetine relieves postoperative pain and lowers wound temperature in centrally sensitized patients undergoing total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. J Clin Med. 2021;10(13):2809.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Li H, Zeng WN, Ding ZC, et al. Duloxetine reduces pain after total hip arthroplasty: a prospective, randomized controlled study. BMC Musculoskelet Disord. 2021;22(1):492.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Rienstra W, Blikman T, Dijkstra B, et al. Effect of preoperative duloxetine treatment on postoperative chronic residual pain after total hip or knee arthroplasty: a randomised controlled trial. BMJ Open. 2021;11(11):e052944.

    Article  PubMed  PubMed Central  Google Scholar 

  26. YaDeau JT, Brummett CM, Mayman DJ, et al. Duloxetine and subacute pain after nnee arthroplasty when added to a multimodal analgesic regimen: a randomized, placebo-controlled, triple-blinded trial. Anesthesiology. 2016;125(3):561–72.

    Article  CAS  PubMed  Google Scholar 

  27. Ljungqvist O, de Boer HD, Balfour A, et al. Opportunities and challenges for the next phase of enhanced recovery after surgery: a review. JAMA Surg. 2021;156(8):775–84.

    Article  PubMed  Google Scholar 

  28. Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet. 2003;362(9399):1921–8.

    Article  PubMed  Google Scholar 

  29. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2-s15.

    Article  PubMed  Google Scholar 

  30. Fillingham YA, Hannon CP, Buvanendran A, et al. Multimodal analgesia for hip and knee arthroplasty: eliminating opioids as the cornerstone of postoperative pain management. J Arthroplasty. 2020;35(10):2695–6.

    Article  PubMed  Google Scholar 

  31. Brannan SK, Mallinckrodt CH, Detke MJ, et al. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies. J Psychiatr Res. 2005;39(2):161–72.

    Article  PubMed  Google Scholar 

  32. Wang CF, Russell G, Wang SY, et al. R-duloxetine and n-methyl duloxetine as novel analgesics against experimental postincisional pain. Anesth Analg. 2016;122(3):719–29.

    Article  CAS  PubMed  Google Scholar 

  33. Wang CF, Russell G, Strichartz GR, et al. The local and systemic actions of duloxetine in allodynia and hyperalgesia using a rat skin incision pain model. Anesth Analg. 2015;121(2):532–44.

    Article  CAS  PubMed  Google Scholar 

  34. Onuţu AH. Duloxetine, an antidepressant with analgesic properties - a preliminary analysis. Rom J Anaesth Intensive Care. 2015;22(2):123–8.

    PubMed  PubMed Central  Google Scholar 

  35. Miller A, Roth T, Roehrs T, et al. Correlation between sleep disruption on postoperative pain. Otolaryngol Head Neck Surg. 2015;152(5):964–8.

    Article  PubMed  Google Scholar 

  36. Kluge M, Schüssler P, Steiger A. Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depression. Eur Neuropsychopharmacol. 2007;17(8):527–31.

    Article  CAS  PubMed  Google Scholar 

  37. Chellappa SL, Aeschbach D. Sleep and anxiety: From mechanisms to interventions. Sleep Med Rev. 2022;61:101583.

    Article  PubMed  Google Scholar 

  38. Doghramji K. Sleep extension in sleepy individuals reduces pain sensitivity: new evidence regarding the complex, reciprocal relationship between sleep and pain. Sleep. 2012;35(12):1587–8.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

None.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Orthopedics, Affiliated Dongguan Hospital, Southern Medical University (Dongguan People’s Hospital), Dongguan, 523000, China

    Hongzhi Zhong, Jianhang Li, Yuxiang Chen, Yicong Huang, Zhishen Wen & Jun Zhao

Authors
  1. Hongzhi Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jianhang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuxiang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yicong Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhishen Wen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jun Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Zhao.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 782 kb)

Supplementary file2 (DOCX 13 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhong, H., Li, J., Chen, Y. et al. Effect of duloxetine on pain and opioid consumption after total knee and hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials. Int J Clin Pharm 46, 14–25 (2024). https://doi.org/10.1007/s11096-023-01593-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-023-01593-x

Keywords

Search

Navigation